NEWS HOME

»

COVISHIELD

 

Restricted emergency use approvals to Covishield, Covaxin not granted in haste: SC

The Supreme Court on Monday said the material provided by the Centre does not warrant the conclusion that restricted emergency use approvals were granted to Covishield and Covaxin in haste, without thorough review of relevant data.... read..

---

 

COVID-19: India hands over Made in India Covishield vaccines to Cambodia

India on Tuesday handed over to Cambodia 325,000 doses of Made in India Covishield vaccines under the Quad Vaccine Partnership scheme.... read..

---

 

Slashed COVID-19 vaccine Covishield's prices to ensure more accessibility, reach, says SII's Adar Poonawalla

The decision to slash the prices of the precautionary dose of the COVID-19 vaccine Covishield, which is now available for all adults, was taken to make it more affordable, accessible and within reach of the masses, Chief Executive Officer (CEO) of Serum I... read..

---

 

COVID vaccine: Covishield's price reduced from Rs 600 to Rs 225 per dose at pvt hospitals

Pune-based Serum Institute of India (SII) on Saturday announced that it has revised the price of its COVID vaccine Covishield for private hospitals from Rs 600 to Rs 225 per dose."We are pleased to announce that after discussion with the Central Governmen... read..

---

 

DCGI grants conditional market approval for Covaxin, Covishield

The Drugs Controller General of India (DCGI) on Thursday granted conditional regular market approval for COVID-19 vaccines Covaxin and Covishield for restricted use in emergency situations in the adult population.... read..

---

 

Covaxin, Covishield given normal new drug permission in adult population with conditions: Health Minister

Union Health Minister Dr Mansukh Mandaviya on Thursday said that the Central Drugs Standard Control Organisation (CDSCO) has now upgraded the permission for Covaxin and Covishield from restricted use in emergency situations to normal new drug permission i... read..

---

 

DGCI grants conditional market approval for Covaxin, Covishield

The Drugs Controller General of India (DCGI) on Thursday granted conditional regular market approval for COVID-19 vaccines Covaxin and Covishield for restricted use in emergency situations in the adult population.... read..

---

 

Regular market approval to Covishield, Covaxin expected soon after final price fixation: Sources

The regular market approval from Drugs Controller General of India (DCGI) to COVID-19 vaccine Covishield and Covaxin is expected soon, but only after price fixation which is still underway, official sources told ANI on Wednesday.... read..

---

 

Covishield, Covaxin cleared for regular market approval

India's two main vaccines -- Bharat Biotechs Covaxin and Serum Institute of India's Covishield -- on Wednesday got the nod for regular market authorisation.... read..

---

 

SEC recommends regular market approval to Covaxin, Covishield for adults

The Drugs Controller General of India's (DCGI) subject expert committee (SEC) has recommended the regular market approval to Serum Institute of India and Bharat Biotech for their COVID-19 vaccines Covaxin and Covishield with conditions for the adult popul... read..

---

 

SEC asks for more data to grant full market approval to Covaxin and Covishield

The Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) will continue thorough review of data submitted by the Serum Institute of India (SII) and Bharat Biotech for granting full market approval to Covaxin and Covishield, sources tol... read..

---

 

Jharkhand man paralysed for four years says he is able to move and speak after taking Covishield vaccine

A 55-year-old man, who had become paralysed and lost his voice four years ago in an accident, said he was able to move and speak after he was given Covishield vaccine on January 4.... read..

---

 

DCGI's SEC to review applications of Bharat Biotech, SII for full market approval to Covaxin, Covishield today: Sources

Drugs Controller General of India (DCGI)'s Subject Expert Committee will review applications of Bharat Biotech and Serum Institute of India (SII) for full market approval to Covaxin and Covishield respectively on Friday, sources said.... read..

---

 

Serum Institute applies for full market authorisation of Covishield

Pune-based Covid vaccines manufacturer Serum Institute has requested the Indian health ministry and Central Drugs Standard Control Organisation (CDSCO) for full market authorisation for its Covishield vaccine.... read..

---